FLT3LG and familial pancreatic carcinoma: In addition, tumoral Flt3L expression was identified as a predictive biomarker in a cohort of patients with pancreatic cancer that correlated with improved survival and was independent of other clinical parameters, similar to what we observed in our study [29].